EUR/USD 1.16932
0.508%
Gold 4597.92
2.004%
Oil 58.667
0.084%
USD/JPY 157.757
-0.077%
GBP/USD 1.34637
0.430%
GBP/JPY 212.405
0.354%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
The Eurozones January Sentix investor confidence index will be released in ten minutes.On January 12th, Hengrui Medicine announced that its subsidiary, Suzhou Shengdiya Biopharmaceutical Co., Ltd., has had its injectable SHR-1826 included in the Breakthrough Therapy Product List by the Center for Drug Evaluation of the National Medical Products Administration. SHR-1826 is an antibody-drug conjugate targeting c-Met. It binds specifically to the target antigen on the surface of tumor cells, is internalized into the tumor cells, and then kills them. A search reveals that a similar product, ABBV-399, received accelerated approval from the US FDA in May 2025 for the treatment of adult patients with advanced/metastatic non-squamous non-small cell lung cancer who have previously received systemic therapy and have high c-Met protein expression. To date, the cumulative R&D investment in the SHR-1826 injectable project is approximately RMB 125.5 million.On January 12th, Sanfangxiang issued an announcement stating that, according to preliminary calculations by its finance department, the company expects a negative net profit attributable to shareholders of the listed company for 2025, resulting in an operating loss for the year. The company will strictly comply with the relevant regulations, including the "Shanghai Stock Exchange Listing Rules," and expedite its financial accounting work, disclosing its 2025 performance forecast as soon as possible. The final financial data will be subject to the companys officially released 2025 annual report.On January 12, Longxun Technology announced that it submitted an application to the Hong Kong Stock Exchange for an overseas public offering of H shares and listing on the Main Board of the Hong Kong Stock Exchange on December 22, 2025, and published the application materials for this offering on the Hong Kong Stock Exchange website on the same day. The company has submitted the filing application materials for this offering to the China Securities Regulatory Commission (CSRC) in accordance with relevant regulations, and the CSRC recently accepted them.On January 12, it was reported that U.S. Immigration and Customs Enforcement (ICE) officers shot and killed 37-year-old Ryan Goode during an immigration enforcement operation in Minneapolis on January 7, sparking days of protests across the United States. On January 11, protests entered their sixth day in Minneapolis, New York, Oakland, Atlanta, and other cities. Residents of Minneapolis stated that this forced immigration enforcement by the federal government was tantamount to "terrorism." Other protesters stated that the U.S. governments attacks on immigrants domestically and its imperialist aggression abroad should both be opposed.

Gold Price Prediction: XAUUSD will acquire bullish momentum if the Fed rejects a September rate rise

Alina Haynes

Jun 13, 2022 15:37

截屏2022-06-13 下午3.27.32.png 


On Monday, gold reached a fresh five-week high of $1,879 before retreating. On Wednesday of this week, the Federal Reserve is expected to make a decision. According to the research, the yellow metal might acquire positive momentum if Chairman Jerome Powell opposes a rate rise in September.

Fed is in the spotlight this week

"It is largely anticipated that the Fed would increase its policy rate by 50 basis points to the range of 1.25 percent to 1.5 percent." It shouldn't come as a surprise if the Fed opts for another 50-basis-point rate hike in July.

 

"The primary issue is whether the Federal Reserve will halt rate rises in September. If the Fed or FOMC Chairman Jerome Powell opposes a rate rise in September, this might be interpreted as dovish signaling and lead to a decrease in US Treasury bond rates. In such a case, gold will certainly gain upward momentum. Alternatively, if the Fed keeps the door open for another rate hike in September, the dollar should continue to outperform its competitors and weigh on XAUUSD.

Suggestion